Ligand Pharmaceuticals | Stammkapital



Ordinary Share Capital Veränderung Datum
Amgen USD 33.58B 45M 2025-03
Arrowhead Research USD 230K 12K 2025-03
Baxter International USD 683M 0 2024-12
Bristol-Myers Squibb USD 292M 0 2025-03
Eli Lilly USD 592.6M 200K 2025-03
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 1.35B 1000K 2025-03
Glaxosmithkline GBP 1.35B 0 2024-12
Insmed USD 1.82M 25K 2025-03
Ionis Pharmaceuticals USD 159K 1000 2025-03
Ligand Pharmaceuticals USD 20K 0 2025-03
MacroGenics USD 628K 1000 2024-12
Merck USD 1.79B 0 2025-03
Pacira USD 47K 0 2025-03
Pfizer USD 481M 1000K 2025-03
Veracyte USD 78K 1000 2024-12



Ligand Pharmaceuticals Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.